within Pharmacolibrary.Drugs.ATC.C;

model C07FB12
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.12,
    Cl             = 2.5,
    adminDuration  = 600,
    adminMass      = 0.005,
    adminCount     = 1,
    Vd             = 0.01,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Nebivolol and amlodipine is a fixed-dose combination antihypertensive medication that contains nebivolol, a selective beta-1 adrenergic blocker with vasodilatory properties, and amlodipine, a long-acting dihydropyridine calcium channel blocker. The combination is approved and widely used today for the treatment of essential hypertension in adult patients where monotherapy is insufficient.</p><h4>Pharmacokinetics</h4><p>Estimated typical pharmacokinetic parameters for fixed-dose combination in adults after oral administration, based on individual data for nebivolol and amlodipine due to lack of published parameters for the combination product itself.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C07FB12;
